knowledge -WSS

knowledge

author：fashion 2025-09-27 12:22:08 - browse：56

Light hits on the portrait of George Washington on a one dollar bill. The portrait is surrounded by white and red tablets coming out of a pill bottle, as well as some coins — coverage from STAT — Adobe

WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program from being able to negotiate prices for their products, including suing the government. Experts say their efforts might actually benefit Biden by reminding voters that he’s taking on big drug companies.

When Democrats passed a law directing Medicare to negotiate drug prices, it was considered a major achievement. The new law, two decades in the making, gives Biden an accomplishment to both tout for himself and criticize Republicans for opposing — no Republicans voted to let Medicare negotiate drug prices.

Medicare price negotiation is popular with voters, as are the law’s price-inflation limits, and it includes additional, direct benefits for older adults that are easy to understand. It caps annual out-of-pocket retail-drug spending for seniors and people with disabilities, and it caps their monthly spending on insulin at $35.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： STAT Summit: Biotech founders on deal

WSS

How AI helped researchers track recovery from depression

Thermo Fisher plant for manufacturing gene therapies to expand

Senate HELP committee spars over health care workforce policies

CDC's new outbreak response network to include Northeastern

Microbiome research is starting to find links to chronic diseases

CDC advisers recommend seasonal use of Pfizer RSV shot

explore

knowledge

focus

Medicare details structure of new drug price negotiation program

Intarcia’s device

Moonlake's readout produced a cash windfall. Risks remain

Senate HELP committee spars over health care workforce policies

After affirmative action ruling, medical educators look to 'holistic review'

Why are Kaiser Permanente staff considering a strike?

Hepatitis C has a cure — but many Americans still lack access to it

CEOs share strategies for surviving biotech slump

Supreme Court strikes down use of affirmative action

Impact of Dobbs ruling felt at reproductive medicine meeting

knowledge

CDC advisers recommend seasonal use of Pfizer RSV shot

Why health workers in Gaza are injured or die at high rates

Intarcia’s device

Senators: Long

It's been 20 years since Dolly the sheep. Where's my clone?

UnitedHealth’s board chair also owns a personal investment firm

entertainment

Wikipedia

explore

Wikipedia